Key words: adequacy target; coefficient of variation; creatinine clearance; Kt/V; peritoneal dialysis Background. The achievement of dialysis adequacy targets in peritoneal dialysis (PD) is assessed by the calculation of the Kt/V and creatinine clearance (C Cr ) obtained by collecting dialysate and urine, usually two or three times a year. Prescription decisions are based Introduction on such adequacy assessments, regardless of any variability in the single measurements. The aim of our Dialysis replacement therapy is only partially able to study was to assess the day-to-day variability of substitute the kidney's blood purification function and common dialysis adequacy parameters and to evaluate the adequacy of this therapy is mainly assessed by its impact on the adequacy indexes in PD.
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quantification procedures. Its adequacy in haemodiaMethods. Twenty-four patients (14 CAPD, 10 APD) lysis is evaluated from the degree of urea removal at two centres were studied by means of a triple according to the urea kinetic model ( UKM ) [1, 2] dialysate and urine collection for a period of 1 week. while in peritoneal dialysis (PD) both urea and creatinVariability in the findings for a given patient was ine (Cr) kinetics from fluid collections are used [3] [4] [5] . expressed by the coefficient of variation (CV%) calcu-In PD, measuring urea clearance normalized to the lated for peritoneal (p), renal, and total (tot) adequacy distribution compartment ( Kt/V ) and Cr clearance parameters. The target Kt/V and C Cr values were (C Cr ) normalized to 1.73 m2 of body surface area recalculated on the basis of variability.
(C Cr /1.73) has become a common tool for evaluating Results. Kt/V was less variable (CV 4.0 and 4.4% for the adequacy of therapy and deciding the dialysis dose peritoneal Kt/V (pKt/V ) and total Kt/V (totKt/V ) prescription. The exact target values for these adequacy respectively) than C Cr (4.7 and 6.0% for peritoneal indexes in PD are still under investigation. creatinine clearance (pC Cr ) and total creatinine clearInitially, a theoretical approach set the target level ance (totC Cr ) respectively) and proved to be a more for weekly Kt/V and C Cr at 2.0 and 60 l, respectively reliable indicator of adequacy in terms of the CV. Both [6 ] , whereas the clinical approach suggested 1.7 and variability parameters became worse if renal clearance 50 l respectively [7] . Recently, the CANUSA study on was added to peritoneal clearance. CV in APD proved CAPD suggested that higher clearances are associated to be no different from CAPD for all the parameters with a better survival and lower morbidity, so weekly considered. In our centres dialysis adequacy target total Kt/V from 2.1 to 2.3 and C Cr from 70 to 80 l correction for variability provided safe values for were each associated with an improvement in the weekly Kt/V (pKt/V=1.78-2.10 and totKt/V= expected 2-year survival from 78 to 81% [5] . The latest 1.82-2.15 target 1.7-2.0) and C Cr /1.73 (pC Cr = and most thorough PD guidelines, published as the 53.7-64.4 l and totC Cr =55.1-66.1 l; target 50-60 l ). Dialysis Outcome Quality Initiative by the National Conclusions. Evaluating the adequacy of PD by means Kidney Foundation [8] , have set the weekly targets at of a single measurement should take into account the 2.0 for Kt/V and 60 l for C Cr in CAPD with an increase weekly variability as demonstrated by a triple dialysate of 5% for CCPD and of 10% for NIPD based on the and urine collection. Standard adequacy targets can opinion of the major experts that intermittent or be corrected to allow for variability. Thus one can variably efficient treatments need an elevation of the obtain safe values for prescription decisions based on targets [8] . a single collection result.
It is considered optimal practice in PD to collect biological fluids for the calculation of adequacy paraCorrespondence and offprint requests to: Giovambattista Virga, meters every 4 months [8], but this is usually done no were all normalized for a 1.73 m2 body surface area (BSA). on a single measurement can thus influence clinical BSA was calculated using the du Bois formula [11] and body outcome for many months.
water ( V ) was calculated using the Watson formula [12] .
In general, the evaluation of a measurement is based The aim of our study was to assess the day-to-day ory variability. variability of common dialysis adequacy parameters and to evaluate its impact on the adequacy indexes in PD.
Statistical analysis
Continuous variables were expressed as means (M )±standard deviation (SD) or as medians (interquartile
Subjects and methods
range) if data were not normally distributed.
Variability between a given patient's three assessments was
Patients
expressed by the coefficient of variation (CV%=SD/M×100) calculated for each study parameter. CV was also calculated Twenty-four patients at two centres (Camposampiero 19, for BSA and V. Individual CVs for each parameter were Treviso 5) were studied. Ten patients were receiving tidal summarized using the median value (interquartile range) and APD (3 NTPD, 7 CTPD) and 14 were on CAPD.
its 95% confidence interval [15] and expressed study populaPatients on APD were treated for 8-10 h/night (tidal tion variability between the three collections. A comparison 50-75%) and 0-2 daily dwells while those on CAPD had between APD CVs and CAPD CVs was drawn using the four exchanges every 24 h. The daily volume prescription non-parametric Mann-Whitney U-test. was 21.1±3.3 l in APD (range 14.5-25.8 l ) and 8.5±0.7 l in It is assumed that the variability observed randomly affects CAPD (range 6.8-10.4 l ). Four patients on APD were anuric. every single adequacy measurement, but we considered only During the week of the study, the dialysis prescription the positive portion as clinically dangerous because a single remained unchanged. All patients were metabolically stable, false high measurement can lead to a prescription being had been free from acute disease or peritonitis for at least 3 considered adequate when in fact it is not. Consequently, months, and had performed a standard peritoneal equilibra-the standard target values assumed from the literature for tion test [10] no more than 6 months before the study. All Kt/V and C Cr were recalculated to give 'safe' target values, patients enrolled in the study gave their informed consent.
including the upper limit of the 95% confidence interval of the median CV value as a correction factor (CF ) as follows: safe target=standard target+(standard target×CF ).
Study procedure
The null hypothesis was rejected for all tests with twotailed alpha values lower than 0.05. JMP 3.02 (SAS, Cary, Dialysate and urine were collected for 24 h three times in NC, USA) software and Instat 2.03 (Graphpad, San Diego, one week by all patients. Samples of dialysate and urine were CA, USA) software on Macintosh (Apple, Cupertino, CA, obtained after they had been weighed and mixed. Dialysate USA) hardware were used for the statistical analysis. volume was assumed to equate to its weight (1 kg=1 l ), disregarding any difference between dialysate and distilled water. Dialysate was analysed for urea, Cr, and glucose, and urine was analysed for urea and Cr, using standard laborat-Results ory methods.
For the Camposampiero patients the dialysate Cr was
The features of the study population are summarized corrected for glucose with an over-estimation correction factor of 0.0001806 mg/dl of Cr every mg/dl of glucose, while in Table 1 , including mean or median values for the for the Treviso patients an enzymatic assay was used with study parameters obtained from all determinations.
no need to adjust for glucose interference (Bayer, Tarrytown,
The mean or median values for the parameters NY, USA). At the time of each biological fluid collection, studied in the three separate daily collections are patients were weighed and a blood sample was obtained for summarized in Table 2 .
Cr and urea assay in steady-state conditions (at 8 a.m.,
The CV values ( Table 3) demonstrate that peritoneal fasting, for CAPD patients; between 2 and 5 p.m., not clearances are much more constant than renal clearfasting, for APD patients).
ances over a period of one week and the sum of their Eight parameters were studied: peritoneal (pC Cr ) and total indexes makes the variability worse, especially for C Cr .
creatinine clearance (totC Cr ), peritoneal, renal, and total Kt/V Kt/V is less variable than C Cr and proves a more (pKt/V, rKt/V, totKt/V ), glomerular filtration rate (GFR), diuresis, and ultrafiltration ( UF ). GFR, pC Cr and totC Cr suitable index in terms of variability. causes. In fact, it can stem from physiological oscillations and BW and V measurement inaccuracies, or from hypothetical variations in renal function or periComparison between the CVs for CAPD and APD toneal permeability, but some degree of analytical showed no statistical differences ( Table 4) . variability in the laboratory dosages might also be The results of the laboratory variability analysis, taken into account. Moreover, other causes could be overall for the two centres, are given in Table 5 .
involved, such as a discontinuous compliance with A recalculation of the adequacy target to ensure safe therapy prescription or collection instructions, or values that take their variability into account involves methodological differences in the weighing, mixing, incrementing pKt/V and totKt/V by 5.0 and 7.3% and sampling of dialysate and urine. respectively, while for pC Cr and totC Cr the increment Individual variability in three peritoneal and renal is 7.4 and 10.2% respectively ( Table 6) .
clearances by the direct quantification method is expressed by the SD of this clearance and the best clearance estimation by the M of real values. To make Discussion this uncertainty or error comparable, the SD/M ratio (CV ) is commonly used, expressed as a percentage [16 ] . In our study population, CVs were not normally Adequacy in PD is commonly evaluated by direct quantification of clearances, and dialysis dose prescrip-distributed, so we have expressed data as median values and interquartile ranges without making any other tion is based on the outcome of a 24-h dialysate and urine collection for the calculation of these parameters. assumptions on distributions.
The day-to-day variability observed should be borne The close relationship of the adequacy targets with the efficacy of PD and all calculations based on a single in mind in prescribing the dialysis dose on the strength of data based on a single measurement and an determination make assessment of these data and the resulting decisions difficult and dubious.
adequacy target is considered as a minimum value. The aim of this study on variability in PD is to prompt A controversial aspect concerns the reliability of a single collection in representing the outcome of a a better interpretation of adequacy results and guide prescription decisions.
4-month period of dialysis (if current guidelines are followed [8]) or of a 6-month period if the test is done
In our study, C Cr is affected by a higher variability than Kt/V ( Table 3 ) that appears to be more reliable twice a year, as is commonly the case.
The major problem with these data concerns the in terms of the CV. Renal parameters (rKt/V and GFR) demonstrate a higher CV and adding their day-to-day variability of renal and peritoneal para- adequate without an optimal Kt/V value [19] because if we add peritoneal CL to GFR, the C Cr /Kt/V ratio increases because the renal C Cr is higher than the renal Rodby et al. [9] . The greater variation in renal parameters is confirmed by their data, too, so both Kt/V and C Cr variability become worse if renal clearance is values to peritoneal clearances makes the variability combined with peritoneal clearance findings ( Table 3) . worse, probably due to a physiological variability in This result is also consistent with the significant relathe severely limited renal function of uraemic patients tionship between intra-method variability in total Cr and to errors in urine collection ( Table 2) .
excretion and residual renal function reported for Laboratory dosage variability played a significant multiple (3) (4) (5) collections in children on PD [23] . The part in the global variability of adequacy indexes in CVs calculated by Rodby et al. were about 75% higher PD (Table 5 ). Laboratory dosage variability was than in our study. Unfortunately, UF, GFR, and 1-2%, which is far from negligible for PD adequacy totC Cr with GFR CVs were not reported. To compare parameters that show a CV with a range of 4 to 6% our CV for UF we elaborated data published by Fisher ( Table 3) . et al.
[24] on a triple collection to study compliance in Variability between APD and CAPD failed to reveal PD: the calculated median UF CV of 37.7% any statistically significant difference in our study, but (14.8-53.9) was higher than ours, but to the same C Cr in APD demonstrated a high CV, which can be extent (75%) as the other parameters considered by considered as one of the causes of the well-known Rodby et al. inconsistency between Kt/V and C Cr in PD [17] . This We corrected our target values by the median CV, latter aspect of adequacy evaluation in APD is probusing the upper limit of the 95% confidence intervals ably more evident for intermittent techniques in order to consider the variability of our PD patient (NIPD-NTPD) than for continuous treatments population. Using this approach, we have used a safe (CCPD-CTPD).
Our population shows a disagreement between value of variability with a 95% precision. For example, 
